NCT03332758View on ClinicalTrials.gov

Inflammasomes in Cell Death in FTMH, ERM, and RRD

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

April 10, 2018

Study Completion Date

May 1, 2018

Conditions
Retinal DetachmentFull Thickness Macular HoleEpiretinal Membrane
Interventions
PROCEDURE

Pars plana vitrectomy

Standard of care treatment for retinal detachment, macular hole, or epiretinal membrane.

PROCEDURE

External drainage

Standard of care treatment for retinal detachment.

Trial Locations (1)

19107

MidAtlantic Retina-Wills Eye Hospital, Philadelphia

All Listed Sponsors
collaborator

Mid Atlantic Retina

OTHER

lead

Allen C. Ho, MD

OTHER

NCT03332758 - Inflammasomes in Cell Death in FTMH, ERM, and RRD | Biotech Hunter | Biotech Hunter